TransMedics (TMDX) Free Cash Flow Growth (1y) (2019 - 2026)
Powered by 
Analysis
TransMedics (TMDX) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -14.34% |
| 10 | TransMedics | 2.98 Bn | 2.51 Bn | 113.20 Mn | -87.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -87.62% |
| Mar 31, 2026 | 59.44% |
| Dec 31, 2025 | 213.67% |
| Sep 30, 2025 | 249.83% |
| Jun 30, 2025 | 4,121.69% |
| Mar 31, 2025 | 37.21% |
| Dec 31, 2024 | 118.07% |
| Sep 30, 2024 | 63.92% |
| Jun 30, 2024 | 127.22% |
| Mar 31, 2024 | -396.53% |
| Dec 31, 2023 | -392.93% |
| Sep 30, 2023 | -565.76% |
| Jun 30, 2023 | 46.21% |
| Mar 31, 2023 | 52.91% |
| Dec 31, 2022 | 30.80% |
| Sep 30, 2022 | -82.74% |
| Jun 30, 2022 | -130.68% |
| Mar 31, 2022 | -176.99% |
| Dec 31, 2021 | -37.61% |
| Sep 30, 2021 | -45.62% |